{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:47:25Z","timestamp":1792601245534,"version":"4.5.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","award":["825RC764"],"award-info":[{"award-number":["825RC764"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013254","name":"National College Students Innovation and Entrepreneurship Training Program","doi-asserted-by":"publisher","award":["X202011810037"],"award-info":[{"award-number":["X202011810037"]}],"id":[{"id":"10.13039\/501100013254","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["New Microbes and New Infections"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.nmni.2026.101837","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:04:06Z","timestamp":1788307446000},"page":"101837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Shigella infections in the era of antimicrobial resistance: Insights into cephalosporin use"],"prefix":"10.1016","volume":"73","author":[{"given":"Wenqing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutian","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamy Jayne Nelly","family":"Rajaofera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.nmni.2026.101837_bib1","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S1473-3099(18)30475-4","article-title":"Morbidity and mortality due to Shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016","volume":"18","author":"Khalil","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.nmni.2026.101837_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fcimb.2016.00045","article-title":"Shigella diversity and changing landscape: insights for the twenty-first century","volume":"6","author":"Anderson","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"10.1016\/j.nmni.2026.101837_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.BAI-0023-2019","article-title":"Shigella pathogenesis: new insights through advanced methodologies","volume":"7","author":"Schnupf","year":"2019","journal-title":"Microbiol Spectr"},{"issue":"10122","key":"10.1016\/j.nmni.2026.101837_bib4","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0140-6736(17)33296-8","article-title":"Shigellosis","volume":"391","author":"Kotloff","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.nmni.2026.101837_bib5","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1021\/acsinfecdis.0c00889","article-title":"Target product profile and development path for shigellosis treatment with antibacterials","volume":"7","author":"Arnold","year":"2021","journal-title":"ACS Infect Dis"},{"issue":"1","key":"10.1016\/j.nmni.2026.101837_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taac132","article-title":"Burden of Shigella in South Asia: a systematic review and meta-analysis","volume":"30","author":"Muzembo","year":"2023","journal-title":"J Travel Med"},{"key":"10.1016\/j.nmni.2026.101837_bib7","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.3389\/fmicb.2018.03027","article-title":"Characterization and genomic analysis of SFPH2, a novel T7virus infecting shigella","volume":"9","author":"Yang","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.nmni.2026.101837_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2019.100024","article-title":"Potential impact and cost-effectiveness of future ETEC and Shigella vaccines in 79 low- and lower middle-income countries","volume":"2","author":"Anderson","year":"2019","journal-title":"Vaccine X"},{"issue":"2","key":"10.1016\/j.nmni.2026.101837_bib9","first-page":"81","article-title":"Shigella: a highly virulent and elusive pathogen","volume":"1","author":"Zaidi","year":"2014","journal-title":"Curr Trop Med Rep"},{"issue":"Suppl 1","key":"10.1016\/j.nmni.2026.101837_bib10","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1093\/ofid\/ofad651","article-title":"The Enterics for Global Health (EFGH) shigella surveillance study in Pakistan","volume":"11","author":"Ahmed","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.nmni.2026.101837_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00598-23","article-title":"A novel Shiga toxin 2a neutralizing antibody therapeutic with low immunogenicity and high efficacy","volume":"68","author":"Kirkland","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.nmni.2026.101837_bib12","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S1473-3099(22)00879-9","article-title":"Genomic reconstruction and directed interventions in a multidrug-resistant Shigellosis outbreak in Seattle, WA, USA: a genomic surveillance study","volume":"23","author":"Tansarli","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.nmni.2026.101837_bib13","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1186\/s12879-019-4659-y","article-title":"Incidence, clinical implications and impact on public health of infections with Shigella spp. and entero-invasive Escherichia coli (EIEC): results of a multicenter cross-sectional study in the Netherlands during 2016-2017","volume":"19","author":"van den Beld","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.nmni.2026.101837_bib14","article-title":"An outbreak of shigellosis in European travellers returning from Cape Verde","volume":"52","author":"Chandani","year":"2023","journal-title":"New Microbes New Infect"},{"issue":"3","key":"10.1016\/j.nmni.2026.101837_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.nmni.2026.101837_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/ecosalplus.esp-0006-2017","article-title":"A brief history of shigella","volume":"8","author":"Lampel","year":"2018","journal-title":"EcoSal Plus"},{"issue":"1","key":"10.1016\/j.nmni.2026.101837_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjph-2024-002411","article-title":"Global trends in inappropriate use of antibiotics, 2000-2021: scoping review and prevalence estimates","volume":"3","author":"Mulchandani","year":"2025","journal-title":"BMJ Public Health"},{"issue":"sup1","key":"10.1016\/j.nmni.2026.101837_bib18","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1080\/20469047.2017.1409454","article-title":"Guidelines for the treatment of dysentery (shigellosis): a systematic review of the evidence","volume":"38","author":"Williams","year":"2018","journal-title":"Paediatr Int Child Health"},{"issue":"1","key":"10.1016\/j.nmni.2026.101837_bib19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13104-025-07113-6","article-title":"Antibiotic resistance and molecular characterization of clinical Shigella spp. isolated from hospitals located in Tehran and Qazvin cities, Iran","volume":"18","author":"Raoufian","year":"2025","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.nmni.2026.101837_bib20","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.2147\/IDR.S522808","article-title":"Analyzing Shigella in Wuhan: serotypes, antimicrobial resistance, and public health implications","volume":"18","author":"Deng","year":"2025","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.nmni.2026.101837_bib21","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.2147\/IDR.S219755","article-title":"Shigella: Antibiotic-resistance mechanisms and new Horizons for treatment","volume":"12","author":"Ranjbar","year":"2019","journal-title":"Infect Drug Resist"},{"issue":"1","key":"10.1016\/j.nmni.2026.101837_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00203-020-02034-3","article-title":"Shigella sonnei: virulence and antibiotic resistance","volume":"203","author":"Shad","year":"2021","journal-title":"Arch Microbiol"},{"issue":"1","key":"10.1016\/j.nmni.2026.101837_bib23","first-page":"47","article-title":"Enteropathogens and antibiotics","volume":"36","author":"Gonzalez-Torralba","year":"2018","journal-title":"Enferm Infecc Microbiol Cl\u00edn"},{"issue":"1","key":"10.1016\/j.nmni.2026.101837_bib24","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/s41467-018-03949-8","article-title":"Horizontal antimicrobial resistance transfer drives epidemics of multiple Shigella species","volume":"9","author":"Baker","year":"2018","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.nmni.2026.101837_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa113","article-title":"Evidence of failure of oral third-generation cephalosporin treatment for Shigella sonnei infection","volume":"7","author":"Collins","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.nmni.2026.101837_bib26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ijantimicag.2010.11.028","article-title":"Strategies to overcome extended-spectrum \u03b2-lactamases (ESBLs) and AmpC \u03b2-lactamases in shigellae","volume":"37","author":"Livermore","year":"2011","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.nmni.2026.101837_bib27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jmii.2020.01.008","article-title":"Genetic analysis and plasmid-mediated bla(CMY-2) in Salmonella and Shigella and the Ceftriaxone Susceptibility regulated by the ISEcp-1 tnpA-bla(CMY-2)-blc-sugE","volume":"54","author":"Chiu","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"issue":"4","key":"10.1016\/j.nmni.2026.101837_bib28","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/cid\/ciz468","article-title":"Extended-spectrum beta-lactamase acquisition in patients receiving systemic cephalosporin treatment for Salmonella spp. and Shigella spp. infection","volume":"70","author":"Spellerberg","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nmni.2026.101837_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mib.2020.07.007","article-title":"Shigella infection and host cell death: a double-edged sword for the host and pathogen survival","volume":"59","author":"Ashida","year":"2021","journal-title":"Curr Opin Microbiol"},{"issue":"1","key":"10.1016\/j.nmni.2026.101837_bib30","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2023.2280838","article-title":"Pathogenicity and virulence of Shigella sonnei: a highly drug-resistant pathogen of increasing prevalence","volume":"14","author":"Matanza","year":"2023","journal-title":"Virulence"},{"issue":"2","key":"10.1016\/j.nmni.2026.101837_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9020451","article-title":"The shigella type III secretion system: an overview from top to bottom","volume":"9","author":"Muthuramalingam","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.nmni.2026.101837_bib32","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fcimb.2017.00064","article-title":"How do the virulence factors of shigella work together to cause disease?","volume":"7","author":"Mattock","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.nmni.2026.101837_bib33","doi-asserted-by":"crossref","DOI":"10.2147\/DDDT.S25757","article-title":"Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies","author":"Kim","year":"2012","journal-title":"Drug Des Devel Ther"},{"issue":"6","key":"10.1016\/j.nmni.2026.101837_bib34","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.immuni.2018.04.014","article-title":"Human enteric alpha-Defensin 5 promotes shigella infection by enhancing bacterial adhesion and invasion","volume":"48","author":"Xu","year":"2018","journal-title":"Immunity"},{"issue":"11 Pt 2","key":"10.1016\/j.nmni.2026.101837_bib35","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.lpm.2007.03.001","article-title":"Shigellosis or bacillary dysentery","volume":"36","author":"Nicolas","year":"2007","journal-title":"Presse Med"},{"issue":"3","key":"10.1016\/j.nmni.2026.101837_bib36","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1128\/AAC.02360-12","article-title":"Outbreak of infections caused by Shigella sonnei with reduced susceptibility to azithromycin in the United States","volume":"57","author":"Sj\u00f6lund Karlsson","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.nmni.2026.101837_bib37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1017\/S0950268812001677","article-title":"The Shigella human challenge model","volume":"141","author":"Porter","year":"2012","journal-title":"Epidemiol Infect"},{"issue":"2","key":"10.1016\/j.nmni.2026.101837_bib38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1089\/apb.2022.0046","article-title":"The biosafety research road map: the search for evidence to support practices in the laboratory-shigella spp","volume":"28","author":"Blacksell","year":"2023","journal-title":"Appl Biosaf"},{"issue":"3","key":"10.1016\/j.nmni.2026.101837_bib39","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1016\/S2214-109X(18)30483-2","article-title":"Burden of enterotoxigenic Escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis","volume":"7","author":"Anderson","year":"2019","journal-title":"Lancet Global Health"},{"issue":"1","key":"10.1016\/j.nmni.2026.101837_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1586\/14787210.2015.983902","article-title":"Treatment of drug-resistant Shigella infections","volume":"13","author":"Klontz","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"8","key":"10.1016\/j.nmni.2026.101837_bib41","first-page":"CD006784","article-title":"Antibiotic therapy for Shigella dysentery","volume":"2010","author":"Christopher","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nmni.2026.101837_bib42","series-title":"Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1","year":"2005"},{"issue":"3","key":"10.1016\/j.nmni.2026.101837_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02337-21","article-title":"Clinical and genomic investigation of an international Ceftriaxone- and Azithromycin-resistant Shigella sonnei cluster among men who have sex with men, Montreal, Canada 2017-2019","volume":"10","author":"Gaudreau","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"1","key":"10.1016\/j.nmni.2026.101837_bib44","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s42003-021-01905-9","article-title":"Evolutionary histories and antimicrobial resistance in Shigella flexneri and Shigella sonnei in Southeast Asia","volume":"4","author":"Chung","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.nmni.2026.101837_bib45","series-title":"Global antibiotic resistance surveillance report 2025","year":"2025"},{"issue":"6","key":"10.1016\/j.nmni.2026.101837_bib46","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3201\/eid2206.152088","article-title":"Shigella antimicrobial drug resistance mechanisms, 2004-2014","volume":"22","author":"Nuesch-Inderbinen","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.nmni.2026.101837_bib47","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S1473-3099(25)00118-5","article-title":"The WHO bacterial priority pathogens list 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance","volume":"25","author":"Sati","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.nmni.2026.101837_bib48","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/cid\/ciaa363","article-title":"Clinical outcomes of drug-resistant shigellosis treated with Azithromycin in Bangladesh","volume":"72","author":"Houpt","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.nmni.2026.101837_bib49","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41467-023-36222-8","article-title":"Rapid emergence of extensively drug-resistant Shigella sonnei in France","volume":"14","author":"Lefevre","year":"2023","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.nmni.2026.101837_bib50","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1093\/jac\/dkx268","article-title":"Shigella species epidemiology and antimicrobial susceptibility: the implications of emerging azithromycin resistance for guiding treatment, guidelines and breakpoints","volume":"72","author":"Brown","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.nmni.2026.101837_bib51","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11033-025-11420-3","article-title":"Investigation of the azithromycin resistance rate and related genes involved in this resistance in clinical Shigella species collected from children with diarrhea in Ahvaz, Southwest Iran","volume":"53","author":"Shahi","year":"2026","journal-title":"Mol Biol Rep"},{"issue":"4","key":"10.1016\/j.nmni.2026.101837_bib52","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/jac\/dkh413","article-title":"Extended-spectrum \u03b2-lactamase-mediated third-generation cephalosporin resistance in Shigella isolates in Bangladesh","volume":"54","author":"Rahman","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.nmni.2026.101837_bib53","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/jac\/dks061","article-title":"Cephalosporin-resistant Shigella flexneri over 9 years (2001-09) in India","volume":"67","author":"Taneja","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.nmni.2026.101837_bib54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/INF.0000000000004965","article-title":"Shigella PCR-positive gastroenteritis in children: insights from a comparison between culture-positive and culture-negative cases","volume":"45","author":"Beeri","year":"2026","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10.1016\/j.nmni.2026.101837_bib55","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/00006454-200011000-00006","article-title":"Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children","volume":"19","author":"Leibovitz","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.nmni.2026.101837_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.712007","article-title":"Understanding beta-lactam-induced lysis at the single-cell level","volume":"12","author":"Wong","year":"2021","journal-title":"Front Microbiol"},{"issue":"9","key":"10.1016\/j.nmni.2026.101837_bib57","article-title":"Cefotaxime versus ceftriaxone: a comprehensive comparative review","volume":"16","author":"Sharma","year":"2024","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.nmni.2026.101837_bib58","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/tropej\/fmp118","article-title":"Emergence of resistance to third-generation cephalosporin in Shigella--A case report","volume":"56","author":"Mandal","year":"2009","journal-title":"J Trop Pediatr"},{"issue":"3","key":"10.1016\/j.nmni.2026.101837_bib59","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3201\/eid0703.017313","article-title":"Third-generation cephalosporin resistance in Shigella sonnei, Argentina","volume":"7","author":"Radice","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.nmni.2026.101837_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e12383","article-title":"Molecular characterization of extended-spectrum cephalosporin and fluoroquinolone resistance genes in Salmonella and Shigella isolated from clinical specimens in Thailand","volume":"8","author":"Sriyapai","year":"2022","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.nmni.2026.101837_bib61","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/infdis\/162.5.1107","article-title":"Antimicrobial resistance of Shigella isolates in the USA: the importance of international travelers","volume":"162","author":"Tauxe","year":"1990","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.nmni.2026.101837_bib62","article-title":"South Asia as a reservoir for the global spread of ciprofloxacin-resistant shigella sonnei: a cross-sectional study","volume":"13","author":"von Seidlein","year":"2016","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.nmni.2026.101837_bib63","article-title":"Whole-genome sequencing of Shigella for surveillance purposes shows (inter)national relatedness and multidrug resistance in isolates from men who have sex with men","volume":"9","author":"van den Beld","year":"2023","journal-title":"Microb Genom"},{"issue":"5","key":"10.1016\/j.nmni.2026.101837_bib64","article-title":"Whole genome sequence analysis of Shigella from Malawi identifies fluoroquinolone resistance","volume":"7","author":"Stenhouse","year":"2021","journal-title":"Microb Genom"},{"issue":"1","key":"10.1016\/j.nmni.2026.101837_bib65","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12879-024-10266-7","article-title":"Molecular epidemiology of extended-spectrum beta-lactamases and carbapenemases-producing Shigella in Africa: a systematic review and meta-analysis","volume":"25","author":"Somda","year":"2025","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.nmni.2026.101837_bib66","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jgar.2018.08.012","article-title":"Prevalence and characterisation of third-generation cephalosporin-resistant Shigella flexneri isolates from Jiangsu Province, China, 2013-2015","volume":"15","author":"Liu","year":"2018","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.nmni.2026.101837_bib67","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.meegid.2014.11.023","article-title":"Possible transfer of plasmid mediated third generation cephalosporin resistance between Escherichia coli and Shigella sonnei in the human gut","volume":"30","author":"Rashid","year":"2015","journal-title":"Infect Genet Evol"},{"issue":"2","key":"10.1016\/j.nmni.2026.101837_bib68","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1128\/AAC.49.2.801-803.2005","article-title":"Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b","volume":"49","author":"Hata","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.nmni.2026.101837_bib69","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/QCO.0000000000000960","article-title":"Resistance in Enteric Shigella and nontyphoidal Salmonella: emerging concepts","volume":"36","author":"Yang","year":"2023","journal-title":"Curr Opin Infect Dis"},{"issue":"2","key":"10.1016\/j.nmni.2026.101837_bib70","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00286-21","article-title":"A conjugative IncI1 plasmid carrying erm (B) and blaCTX-M-104 that mediates resistance to azithromycin and cephalosporins","volume":"9","author":"Yang","year":"2021","journal-title":"Microbiol Spectr"},{"issue":"7","key":"10.1016\/j.nmni.2026.101837_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11071709","article-title":"A tale about shigella: Evolution, plasmid, and virulence","volume":"11","author":"Haidar-Ahmad","year":"2023","journal-title":"Microorganisms"},{"issue":"6","key":"10.1016\/j.nmni.2026.101837_bib72","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1128\/JCM.00427-08","article-title":"CTX-M-15-Producing Shigella sonnei strain from a Czech patient who traveled in Asia","volume":"46","author":"Hrab\u00e1k","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.nmni.2026.101837_bib73","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00253-025-13632-w","article-title":"Genomic insights into Shigella species isolated from small ruminants and manure in the North West Province, South Africa","volume":"109","author":"Motlhaping","year":"2025","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.nmni.2026.101837_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174151","article-title":"A comprehensive review on pharmacology of efflux pumps and their inhibitors in antibiotic resistance","volume":"903","author":"Thakur","year":"2021","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"10.1016\/j.nmni.2026.101837_bib75","doi-asserted-by":"crossref","DOI":"10.3201\/eid2911.221746","article-title":"Genetic characterization of extensively drug-resistant Shigella sonnei infections, Spain, 2021\u20132022","volume":"29","author":"Jacqueline","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.nmni.2026.101837_bib76","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jgar.2025.06.005","article-title":"Regulatory role of ISEcp1 and spacer sequences in bla(CTX-M)-mediated cephalosporin resistance in Shigella","volume":"44","author":"Zhang","year":"2025","journal-title":"J Glob Antimicrob Resist"},{"issue":"3","key":"10.1016\/j.nmni.2026.101837_bib77","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10096-014-2244-2","article-title":"Molecular characterization of the extended-spectrum beta-lactamase (ESBL)-producing Shigella spp. in Shanghai","volume":"34","author":"Li","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"10.1016\/j.nmni.2026.101837_bib78","doi-asserted-by":"crossref","DOI":"10.3201\/eid2908.230411","article-title":"Case of extensively drug-resistant Shigella sonnei infection, United States","volume":"29","author":"Choia","year":"2023","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.nmni.2026.101837_bib79","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1556\/030.2024.02455","article-title":"High prevalence of CTX-M-15 producing Shigella spp. isolated from patients with gastroenteritis in Northeast Iran","volume":"71","author":"Khosravi","year":"2024","journal-title":"Acta Microbiol Immunol Hung"},{"issue":"1","key":"10.1016\/j.nmni.2026.101837_bib80","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40348-022-00152-0","article-title":"Molecular detection and characterization of Shigella spp. harboring extended-spectrum beta-lactamase genes in children with diarrhea in northwest Iran","volume":"9","author":"Sabour","year":"2022","journal-title":"Mol Cell Pediatr"},{"issue":"8","key":"10.1016\/j.nmni.2026.101837_bib81","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1089\/mdr.2017.0204","article-title":"Diarrheagenic Escherichia coli and Shigella with high rate of extended-spectrum beta-lactamase production: two predominant etiological agents of acute diarrhea in Shiraz, Iran","volume":"23","author":"Aminshahidi","year":"2017","journal-title":"Microb Drug Resist"},{"issue":"1","key":"10.1016\/j.nmni.2026.101837_bib82","article-title":"The MFS efflux pump EmrKY contributes to the survival of Shigella within macrophages","volume":"9","author":"Pasqua","year":"2019","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.nmni.2026.101837_bib83","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00293-22","article-title":"Functional role of YnfA, an efflux transporter in resistance to antimicrobial agents in Shigella flexneri","volume":"66","author":"Sen","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.nmni.2026.101837_bib84","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/CMR.00117-14","article-title":"The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria","volume":"28","author":"Li","year":"2015","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"10.1016\/j.nmni.2026.101837_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/biom13050823","article-title":"Role of the MDR efflux pump AcrAB in epithelial cell invasion by Shigella flexneri","volume":"13","author":"Coluccia","year":"2023","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.nmni.2026.101837_bib86","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/07391102.2018.1439404","article-title":"Understanding the resistance mechanism of penicillin binding protein 1a mutant against cefotaxime using molecular dynamic simulation","volume":"37","author":"Behmard","year":"2018","journal-title":"J Biomol Struct Dyn"},{"issue":"7","key":"10.1016\/j.nmni.2026.101837_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2022.183920","article-title":"Shigella viruses Sf22 and KRT47 require outer membrane protein C for infection","volume":"1864","author":"Tinney","year":"2022","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"6","key":"10.1016\/j.nmni.2026.101837_bib88","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.01056-20","article-title":"Mapping the role of AcrAB-TolC efflux pumps in the evolution of antibiotic resistance reveals Near-MIC treatments facilitate resistance acquisition","volume":"5","author":"Langevin","year":"2020","journal-title":"mSphere"},{"issue":"1","key":"10.1016\/j.nmni.2026.101837_bib89","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/0255-0857.108734","article-title":"Cefotaximase and AmpC-producing Shigella flexneri in case of dysentery from southern India","volume":"31","author":"Oommen","year":"2013","journal-title":"Indian J Med Microbiol"},{"issue":"5","key":"10.1016\/j.nmni.2026.101837_bib90","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3343\/alm.2012.32.5.366","article-title":"Quinolone-resistant Shigella flexneri isolated in a patient who travelled to India","volume":"32","author":"Jeon","year":"2012","journal-title":"Ann Lab Med"},{"issue":"4","key":"10.1016\/j.nmni.2026.101837_bib91","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/jac\/dkad031","article-title":"Increasing trend of antimicrobial resistance in Shigella associated with MSM transmission in Barcelona, 2020-21: outbreak of XRD Shigella sonnei and dissemination of ESBL-producing Shigella flexneri","volume":"78","author":"Moreno-Mingorance","year":"2023","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.nmni.2026.101837_bib92","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1128\/AAC.29.4.645","article-title":"Comparative efficacies of single intravenous doses of ceftriaxone and ampicillin for shigellosis in a placebo-controlled trial","volume":"29","author":"Kabir","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.nmni.2026.101837_bib93","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/cid\/ciae575","article-title":"Increased severity of multidrug-resistant Shigella sonnei infections in people experiencing homelessness","volume":"80","author":"Stefanovic","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.nmni.2026.101837_bib94","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s10096-021-04164-y","article-title":"Outbreak of Central American born Shigella sonnei in two youth camps in Belgium in the summer of 2019","volume":"40","author":"Van den Bossche","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.nmni.2026.101837_bib95","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1128\/JCM.43.6.2608-2612.2005","article-title":"Outbreak of dysentery associated with ceftriaxone-resistant shigella sonnei: first report of plasmid-mediated CMY-2-Type AmpC \u03b2-Lactamase resistance in S. sonnei","volume":"43","author":"Huang","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.nmni.2026.101837_bib96","first-page":"1","article-title":"Shigellosis caused by CTX-M type ESBL producing Shigella flexneri in two siblings of rural Nepal: first case report from the country","volume":"2017","author":"Parajuli","year":"2017","journal-title":"Case Rep Infect Dis"},{"issue":"9","key":"10.1016\/j.nmni.2026.101837_bib97","article-title":"Frontiers in shigella vaccine development","volume":"10","author":"MacLennan","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.nmni.2026.101837_bib98","article-title":"Towards a four-component GMMA-Based vaccine against shigella","volume":"10","author":"Micoli","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"10.1016\/j.nmni.2026.101837_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11060723","article-title":"Cefiderocol: systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance","volume":"11","author":"Karakonstantis","year":"2022","journal-title":"Antibiotics"},{"issue":"7","key":"10.1016\/j.nmni.2026.101837_bib100","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1089\/mdr.2019.0235","article-title":"A new phage cocktail against multidrug, ESBL-producer isolates of Shigella sonnei and Shigella flexneri with highly efficient bacteriolytic activity","volume":"26","author":"Shahin","year":"2020","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.nmni.2026.101837_bib101","article-title":"Cefiderocol for the treatment of multidrug-resistant gram-negative bacteria: a systematic review of currently available evidence","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.nmni.2026.101837_bib102","article-title":"The ongoing journey of a shigella bioconjugate vaccine","volume":"10","author":"Martin","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.nmni.2026.101837_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1499325","article-title":"Synergistic efficacy of phage Henu10 with antibiotics against Shigella dysenteriae with insight into phage resistance and fitness trade-offs","volume":"14","author":"Zhao","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.nmni.2026.101837_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1240570","article-title":"Characterizations of novel broad-spectrum lytic bacteriophages Sfin-2 and Sfin-6 infecting MDR Shigella spp. with their application on raw chicken to reduce the Shigella load","volume":"14","author":"Ahamed","year":"2023","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.nmni.2026.101837_bib105","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/s41467-023-37672-w","article-title":"The evolution and international spread of extensively drug resistant Shigella sonnei","volume":"14","author":"Mason","year":"2023","journal-title":"Nat Commun"}],"container-title":["New Microbes and New Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297526001411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297526001411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:25:56Z","timestamp":1792599956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2052297526001411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":105,"alternative-id":["S2052297526001411"],"URL":"https:\/\/doi.org\/10.1016\/j.nmni.2026.101837","relation":{},"ISSN":["2052-2975"],"issn-type":[{"value":"2052-2975","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shigella infections in the era of antimicrobial resistance: Insights into cephalosporin use","name":"articletitle","label":"Article Title"},{"value":"New Microbes and New Infections","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmni.2026.101837","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101837"}}